Annual Shareholders Equity
$7.28 M
-$42.58 M-85.40%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual stockholders equity is $7.28 million, with the most recent change of -$42.58 million (-85.40%) on December 31, 2023.
- During the last 3 years, HEPA annual shareholders equity has fallen by -$33.24 million (-82.03%).
- HEPA annual shareholders equity is now -92.17% below its all-time high of $93.00 million, reached on December 31, 2021.
Performance
HEPA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$406.70 K
-$3.97 M-111.42%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly stockholders equity is -$406.70 thousand, with the most recent change of -$3.97 million (-111.42%) on September 30, 2024.
- Over the past year, HEPA quarterly shareholders equity has dropped by -$16.57 million (-102.52%).
- HEPA quarterly shareholders equity is now -100.35% below its all-time high of $117.57 million, reached on March 31, 2021.
Performance
HEPA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
HEPA Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -85.4% | -102.5% |
3 y3 years | -82.0% | -100.4% |
5 y5 years | +268.6% | -100.4% |
HEPA Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -92.2% | at low | -100.4% | at low |
5 y | 5-year | -92.2% | at low | -100.3% | at low |
alltime | all time | -92.2% | +348.2% | -100.3% | +94.5% |
Hepion Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$406.70 K(-111.4%) |
Jun 2024 | - | $3.56 M(-52.6%) |
Mar 2024 | - | $7.52 M(+3.3%) |
Dec 2023 | $7.28 M(-85.4%) | $7.28 M(-54.9%) |
Sep 2023 | - | $16.16 M(-38.7%) |
Jun 2023 | - | $26.37 M(-29.0%) |
Mar 2023 | - | $37.15 M(-25.5%) |
Dec 2022 | $49.86 M(-46.4%) | $49.86 M(-15.9%) |
Sep 2022 | - | $59.26 M(-12.0%) |
Jun 2022 | - | $67.32 M(-22.3%) |
Mar 2022 | - | $86.64 M(-6.8%) |
Dec 2021 | $93.00 M(+129.5%) | $93.00 M(-9.4%) |
Sep 2021 | - | $102.64 M(-7.3%) |
Jun 2021 | - | $110.72 M(-5.8%) |
Mar 2021 | - | $117.57 M(+190.2%) |
Dec 2020 | $40.52 M(+159.5%) | $40.52 M(+214.8%) |
Sep 2020 | - | $12.87 M(-29.6%) |
Jun 2020 | - | $18.29 M(-2.5%) |
Mar 2020 | - | $18.77 M(+20.2%) |
Dec 2019 | $15.62 M(+690.7%) | $15.62 M(-3.8%) |
Sep 2019 | - | $16.23 M(-10.0%) |
Jun 2019 | - | $18.03 M(+2693.0%) |
Mar 2019 | - | $645.50 K(-67.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $1.98 M(-46.7%) | $1.98 M(-57.6%) |
Sep 2018 | - | $4.65 M(-719.3%) |
Jun 2018 | - | -$751.50 K(-124.6%) |
Mar 2018 | - | $3.05 M(-38.9%) |
Dec 2017 | $3.70 M(-59.1%) | - |
Sep 2017 | - | $4.99 M(-44.9%) |
Jun 2017 | $9.06 M(+587.5%) | $9.06 M(-2450.3%) |
Mar 2017 | - | -$385.40 K(-106.6%) |
Dec 2016 | - | $5.88 M(-296.2%) |
Sep 2016 | - | -$3.00 M(-327.4%) |
Jun 2016 | $1.32 M(-61.7%) | $1.32 M(+1.7%) |
Mar 2016 | - | $1.30 M(-74.0%) |
Dec 2015 | - | $4.98 M(-466.2%) |
Sep 2015 | - | -$1.36 M(-139.6%) |
Jun 2015 | $3.44 M(-217.2%) | $3.44 M(-56.4%) |
Mar 2015 | - | $7.88 M(-8.4%) |
Dec 2014 | - | $8.60 M(+1493.6%) |
Sep 2014 | - | $539.90 K(-118.4%) |
Jun 2014 | -$2.93 M(+1987.7%) | -$2.93 M(-60.1%) |
Mar 2014 | - | -$7.34 M(+1398.8%) |
Dec 2013 | - | -$489.90 K(+51.9%) |
Sep 2013 | - | -$322.60 K |
Jun 2013 | -$140.50 K | - |
FAQ
- What is Hepion Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual shareholders equity year-on-year change?
- What is Hepion Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Hepion Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of HEPA is $7.28 M
What is the all time high annual shareholders equity for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual stockholders equity is $93.00 M
What is Hepion Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, HEPA annual stockholders equity has changed by -$42.58 M (-85.40%)
What is Hepion Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of HEPA is -$406.70 K
What is the all time high quarterly shareholders equity for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly stockholders equity is $117.57 M
What is Hepion Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, HEPA quarterly stockholders equity has changed by -$16.57 M (-102.52%)